CMMB
UBS Group’s Chemomab Therapeutics CMMB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $461 | Sell |
397
-486
| -55% | -$564 | ﹤0.01% | 8495 |
|
|
2025
Q1 | $962 | Buy |
883
+398
| +82% | +$434 | ﹤0.01% | 8284 |
|
|
2024
Q4 | $878 | Sell |
485
-1,803
| -79% | -$3.26K | ﹤0.01% | 8113 |
|
|
2024
Q3 | $3.59K | Buy |
+2,288
| New | +$3.59K | ﹤0.01% | 7035 |
|
|
2023
Q4 | – | Sell |
-141
| Closed | -$126 | – | 8125 |
|
|
2023
Q3 | $126 | Buy |
141
+129
| +1,075% | +$115 | ﹤0.01% | 7681 |
|
|
2023
Q2 | $16 | Sell |
12
-399
| -97% | -$532 | ﹤0.01% | 7623 |
|
|
2023
Q1 | $653 | Sell |
411
-4,218
| -91% | -$6.7K | ﹤0.01% | 7836 |
|
|
2022
Q4 | $14.8K | Sell |
4,629
-259
| -5% | -$829 | ﹤0.01% | 6858 |
|
|
2022
Q3 | $12K | Buy |
+4,888
| New | +$12K | ﹤0.01% | 7048 |
|
|
2022
Q2 | – | Sell |
-885
| Closed | -$4K | – | 9294 |
|
|
2022
Q1 | $4K | Sell |
885
-960
| -52% | -$4.34K | ﹤0.01% | 8219 |
|
|
2021
Q4 | $13K | Buy |
1,845
+94
| +5% | +$662 | ﹤0.01% | 7317 |
|
|
2021
Q3 | $19K | Buy |
1,751
+1,612
| +1,160% | +$17.5K | ﹤0.01% | 6062 |
|
|
2021
Q2 | $3K | Sell |
139
-695
| -83% | -$15K | ﹤0.01% | 7677 |
|
|
2021
Q1 | $24K | Buy |
+834
| New | +$24K | ﹤0.01% | 6184 |
|
|
2020
Q2 | – | Sell |
-2,183
| Closed | -$2K | – | 7077 |
|
|
2020
Q1 | $2K | Buy |
+2,183
| New | +$2K | ﹤0.01% | 6675 |
|
|
2019
Q3 | – | Sell |
-1,418
| Closed | -$6K | – | 7011 |
|
|
2019
Q2 | $6K | Sell |
1,418
-1,317
| -48% | -$5.57K | ﹤0.01% | 6424 |
|
|
2019
Q1 | $19K | Buy |
+2,735
| New | +$19K | ﹤0.01% | 5506 |
|